SANDERS MACHELLE — SEC Form 4 filings
SEC reporting owner CIK 1718020. 10 Form 4 filings on record with FilingPulse; latest filed 2026-08-05.
Transaction summary — filings shown
Covers all 10 filings on record, filed 2024-05-16 to 2026-08-05. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 3 legs across 3 filings — 23,989 shares, $271,375 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 13.
- Largest priced transaction: sale of 9,700 shares @ $18.01 ($174,697) in Fortrea Holdings Inc., filed 2026-08-05.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Fortrea Holdings Inc. (FTRE) | Director | 5 | — | 1 leg · 9,700 sh · $174,697 | 7 |
| BIOCRYST PHARMACEUTICALS INC (BCRX) | Director | 5 | — | 2 legs · 14,289 sh · $96,678 | 6 |
Form 4 filings — SANDERS MACHELLE
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-08-05 | 4 | Fortrea Holdings Inc. (FTRE) | Sale (S): 9,700 @ $18.01 | EDGAR |
| 2026-06-15 | 4 | BIOCRYST PHARMACEUTICALS INC (BCRX) | Grant/award (A): 15,294 @ $0 · Grant/award (A): 33,540 (derivative) @ $0 | EDGAR |
| 2026-06-12 | 4 | Fortrea Holdings Inc. (FTRE) | Option exercise (M): 38,817 @ $0 · Option exercise (M): 38,817 (derivative) @ $0 · Grant/award (A): 12,852 (derivative) @ $0 | EDGAR |
| 2025-11-17 | 4 | BIOCRYST PHARMACEUTICALS INC (BCRX) | Sale (S): 9,600 @ $7.14 | EDGAR |
| 2025-06-16 | 4 | BIOCRYST PHARMACEUTICALS INC (BCRX) | Grant/award (A): 12,500 @ $0 · Grant/award (A): 27,181 (derivative) @ $0 | EDGAR |
| 2025-06-12 | 4 | Fortrea Holdings Inc. (FTRE) | Grant/award (A): 38,817 (derivative) @ $0 | EDGAR |
| 2025-05-16 | 4 | Fortrea Holdings Inc. (FTRE) | Option exercise (M): 7,282 @ $0 · Option exercise (M): 7,282 (derivative) @ $0 | EDGAR |
| 2024-06-17 | 4 | BIOCRYST PHARMACEUTICALS INC (BCRX) | Sale (S): 4,689 @ $6 | EDGAR |
| 2024-06-14 | 4 | BIOCRYST PHARMACEUTICALS INC (BCRX) | Grant/award (A): 6,820 @ $0 · Grant/award (A): 49,933 (derivative) @ $0 | EDGAR |
| 2024-05-16 | 4 | Fortrea Holdings Inc. (FTRE) | Grant/award (A): 7,282 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1718020 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →